The Latest Breaking News on Pharma

Pfizer (PFE) benefited substantially from the COVID-19 pandemic. It pays a more than 3% dividend, making it attractive for investors looking for stable income. The stock has picked up steady momentum, and its robust fundamentals should help the company easily outpace the market in the coming years. Let’s discuss this…

GILD gained prominence during the pandemic, but the company’s COVID-19 drug Veklury registered a decline in sales because of declining COVID-19 cases. However, it beat revenue and earnings estimates in the previous quarter. Will the company be able to record further growth in the coming year? Read more to learn…

Parents advised to be mindful of signs including characteristic rash and red tongue also known as ‘strawberry tongue’

Infections have been found around the country, as authorities warn parents to be vigilant

You can't patent naturally-occurring molecules like psilocybin. That's led to a rush to find a synthetic blend

Emergent BioSolutions has applied to the Food and Drug Administration to sell the opioid overdose-reversal drug over the counter. Addiction experts say it may be a key step to lower fentanyl deaths.

Parents with sick children told the Standard that dozens of pharmacists they visited were completely out of stock

The iron deficiency drug specialist will use the proceeds to mount a campaign on the US market

The clunky word “tripledemic” is now on many lips. It means we now face a winter with three different respiratory viruses with similar symptoms are spreading rapidly, and stressing hospital capacity.